Novotech appoints Dr Yooni Kim as Executive Position of Managing Director for APAC

Novotech, a leading global biotech Contract Research Organization (CRO), has appointed Dr Yooni Kim as an Executive position of Managing Director for the Asia-Pacific (APAC) region

Dr Yooni Kim brings expertise and leadership experience to her new role, with over 25 years experience in the clinical research sector of academia, CROs and pharmaceutical companies. Her leadership was proven by a quantum leap in business growth in the APAC region within the CRO industry.

Dr Kim joined Novotech in 2016 as Executive Director, where she played a pivotal role in the growth of the company’s business in Asia. Following the PPC group merger in 2019, she served as Vice President of Global Clinical Services, leading Novotech’s global clinical services departments and harmonizing Novotech’s approach to clinical trials with stakeholders globally. She holds a B. Pharm from Ewha Womans University and a Ph.D in Preventive Medicine from Seoul National University.

Dr Kim will lead Novotech’s APAC by providing strategic direction to diverse teams and ensuring operational excellence in the region. Dr Kim said, “I am delighted to take this role. I bring a strategic approach to make growing Novotech’s capabilities stronger in the region. I will be organized to prioritise the needs of customers and ensure to deliver exceptional value and service for our customers. I will continuously focus on keeping strong bonds with key opinion leaders (KOLs) and regulatory bodies and reinforcing clinical trial site partnerships in the region. I believe this will help leverage the extensive capabilities of the region to benefit our client’s clinical trials programmes.”

“We are delighted to have Dr Yooni Kim lead our APAC region,” said Dr John Moller, CEO, Novotech. “Her deep understanding of the clinical research landscape in Asia, how this integrates into the global clinical research environment, and her leadership skills, will be invaluable as we continue to expand and strengthen our presence in this critical region.”